维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Hembruff SL"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Cross-resistance studiesof isogenic drug-resistant breast tumor cell lines support recentclinical evidence suggesting that sensitivity to paclitaxel may bestrongly compromised by prior doxorubicin exposure显示文摘	Guo B Villeneuve DJ Hembruff SL	2004	BreastCancer Res Treat2004，85，1：	1
	2	Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance显示文摘	HEMBRUFF SL LABERGE ML VILLENEUVE DJ		0，，：	1
	3	Potent killing of paclitaxel-and doxorubicin-resistant breast cancer cells by cytoplasmic vacuolization显示文摘	Guo B Hembruff SL Villeneuve DJ	2003	Breast Cancer Res and Treat2003，82，2：	1
	4	Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and-independent mechanisms显示文摘	Hembruff SL Jokar I Yang L	2010	Neoplasia2010，12，5：	1
	5	Cross-resis- tance studies of isogenic drug-resistant breast tumour cell lines support recent clinical evidence suggesting that sen- sitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure显示文摘	Guo B Villeneuve D J Hembruff SL	2004	Breast Cancer Res Treat2004，85，1：	1
	6	Potent killing of paclitaxel- and doxorubicin- resistant breast cancer cells by cytoplasmic vacuolization显示文摘	Guo B Hembruff SL Villeneuve DJ	2003	Breast Cancer Res and Treat2003，82，2：	1
	7	Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells显示文摘	Fiskus W Hembruff SL Rao R		0，，02：	1
	8	The optimization of quantitative reverse transcription PCR for verification of cDNA microarray data显示文摘	Hembruff SL Villeneuve DJ Parissenti AM	2005	Anal Biochem2005，345，2：	1
	9	Chemokine signaling in cancer:Implications on the tumor mieroenvironment and therapeutic targeting 显示文摘	Hembruff SL Cheng N	2009	Cancer T- her2009，14，7：	1
	10	Loss of transforming growth factor-beta signaling in mammary fibroblasts en- hances CCL2 secretion to promote mammary tumor pro- gression through macrophage-dependent and independent mechanisms显示文摘	Hembruff SL Jokar I Yang L	2010	Neoplasia2010，12，5：	1
	11	Chemokine signaling in cancer: implications on the tumor microenvironment and therapeutic targeting 显示文摘	Hembruff SL Cheng N	2009	Cancer Ther2009，，：	1
	12	Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure显示文摘	Guo B Villeneuve D J Hembruff SL	2004	Breast Cancer Res Treat2004，85，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费